柏柏林和对对大鼠的偏醇诱导的肝毒性有改善作用
Gamal Shams1, Somia Abd Allah2, Raghda Ezzat3
1Pharmacology Department, Faculty of Veterinary Medicine, Zagazig University, Zagazig, Egypt.
Open veterinary journal
|April 18, 2024
概括
柏柏林和通过增强抗氧化剂活性来保护对抗类诱导的肝损伤. 这种组合疗法在缓解急性肝毒性方面表现有前途.
科学领域:
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
- 生物化学 生物化学
背景情况:
- 降醇 (PCM) 过量服用是药物诱导的肝毒性的主要原因.
- N-乙囊是标准的解毒剂,但需要新的治疗策略.
- 柏柏林 (BBR) 具有已知的抗氧化和抗炎性质.
研究的目的:
- 评估Berberine (BBR) 和的保护作用,单独或组合,对对 (PCM) 诱导的急性肝毒性.
- 评估这些药物对肝功能,氧化应激标志物和免疫反应的影响.
主要方法:
- 成年雄性白色老鼠被给予PCM以诱导肝毒性.
- 大鼠同时接受BBR (150毫克/千克) 和/或 (5毫克/千克) 的治疗.
- 评估包括肝功能测试,抗氧化酶活性,脂质过氧化标志物,免疫标志物和组织病理学分析.
主要成果:
- 结合BBR和显著改善了肝功能参数和抗氧化酶活动.
- 治疗降低了氧化 (NO),甲 (MDA),TNF-α和TGF-β1.1的水平.
- 观察到IgM水平升高和肝脏组织病理学改善.
结论:
- 柏柏林和,单独或一起,增强抗氧化能力.
- 这些药物有效地减轻了类醇诱导的肝毒性.
- 这些发现表明BBR和在管理PCM肝毒性方面可能具有治疗作用.
相关概念视频
Enhanced Elimination of Poison
505
Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
505
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
198
Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
198


